Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Revance Therapeutics (NQ: RVNC )

3.780 +0.050 (+1.34%)
Streaming Delayed Price Updated: 2:02 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

2019 Reports

Form 10-K: Annual Corporate Report
Source: SEC/Edgar
February 27, 2019

2018 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 01, 2018
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 02, 2018
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 08, 2018
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 01, 2018

2017 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 02, 2017
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 03, 2017

2016 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 03, 2016
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 04, 2016
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 09, 2016
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 03, 2016

2015 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 09, 2015
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 06, 2015
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 13, 2015
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 03, 2015

2014 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 12, 2014
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 12, 2014
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 27, 2014
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.